Get started
Author

Jenille Tan

Observed name: Jenille M. Tan
Institution: Genentech
ORCID: 0009-0000-1094-7474
Observed ORCID: 0009-0000-1094-7474
OpenAlex ID: A5062929447
Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies
2008 · Kim Newton, Marissa L. Matsumoto, et al. · Cell · 555
PDF
Reproducible pharmacogenomic profiling of cancer cell line panels
2016 · Peter M. Haverty, Eva Lin, et al. · Nature · 289
Coordination between Two Branches of the Unfolded Protein Response Determines Apoptotic Cell Fate
2018 · Tsun-Kai Chang, David A. Lawrence, et al. · Molecular Cell · 203
PDF
Gene Trap Disruption of the Mouse Heparan Sulfate 6- O -Endosulfatase Gene, Sulf2
2006 · David H. Lum, Jenille Tan, et al. · Molecular and Cellular Biology · 91
Multiple-gene targeting and mismatch tolerance can confound analysis of genome-wide pooled CRISPR screens
2019 · Jean-Philippe Fortin, Jenille Tan, et al. · Genome biology · 43
Validation of Synthetic CRISPR Reagents as a Tool for Arrayed Functional Genomic Screening
2016 · Jenille Tan, Scott E. Martin · PLoS ONE · 41
PDF
CD40 Pathway Activation Status Predicts Response to CD40 Therapy in Diffuse Large B Cell Lymphoma
2011 · Bart Burington, Peng Yue, et al. · Science Translational Medicine · 37
ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer
2019 · Steffan Vartanian, James Lee, et al. · Cancer Research · 25
PDF
Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines
2021 · Line Mygland, Shoshy Alam Brinch, et al. · iScience · 18
PDF
Epiregulon: Single-cell transcription factor activity inference to predict drug response and drivers of cell states
2025 · Tomasz Włodarczyk, Aaron Lun, et al. · Nature Communications · 13
PDF
Abstract 5388: Triple-threat: Inavolisib and giredestrant combine with palbociclib to achieve sustained cell cycle arrest in ER-positive breast cancer models
2022 · Taylor Marohl, Jenille Tan, et al. · Cancer Research · 3
KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077)
2025 · Kyung W. Song, Christy C. Ong, et al. · Molecular Cancer Therapeutics · 2
PDF
Abstract 944: Development of predictive and pharmacodynamic biomarker strategies for GDC-0425, a checkpoint kinase 1 inhibitor, in combination with gemcitabine
2015 · Sami Mahrus, Kelly DuPree, et al. · Cancer Research · 1
Joint analysis of multiply perturbed cells improves statistical power and cost efficiency in Perturb-seq
2026 · Jake Yeung, Jenille Tan, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Supplemental Figure 4 from KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077)
2025 · Kyung W. Song, Christy C. Ong, et al.
PDF
Supplemental Figure 1 from KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077)
2025 · Kyung W. Song, Christy C. Ong, et al.
PDF
Supplemental Figure 5 from KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077)
2025 · Kyung W. Song, Christy C. Ong, et al.
PDF
Supplemental Table 1 from KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077)
2025 · Kyung W. Song, Christy C. Ong, et al.
Supplemental Dataset 1 from KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077)
2025 · Kyung W. Song, Christy C. Ong, et al.
Supplemental Figure 2 from KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077)
2025 · Kyung W. Song, Christy C. Ong, et al.
PDF
Supplemental Table 3 from KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077)
2025 · Kyung W. Song, Christy C. Ong, et al.
Supplemental Figure 3 from KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077)
2025 · Kyung W. Song, Christy C. Ong, et al.
PDF
Supplemental Table 2 from KRAS Codon-Specific Mutations Differentially Toggle PI3K Pathway Signaling and Alter Sensitivity to Inavolisib (GDC-0077)
2025 · Kyung W. Song, Christy C. Ong, et al.
Abstract 3141: Epiregulon infers single-cell transcription factor activity to dissect mechanisms of lineage plasticity and drug response
2023 · Tomasz Wlodarczyk, Jenille Tan, et al. · Cancer Research
Data from ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer
2023 · Steffan Vartanian, James Lee, et al.
Works count: 52
Citation count: 1,321
H-index: 10
I10-index: 10
Year
Topic
Type